A clinical trial of glutathione supplementation in autism spectrum disorders.
Published December, 2011 in Medical Science Monitor
Children with autism had low plasma (blood) GSH, which was restored to normal range with our oral liposomal glutathione, but not transdermal GSH.
The results suggest that oral and transdermal glutathione supplementation may have some benefit in improving some of the transsulfuration metabolites. Future studies among subjects diagnosed with an ASD should further explore the pharmacokinetics of glutathione supplementation and evaluate the potential effects of glutathione supplementation upon clinical symptoms.